Purpose: To map anterior ocular wall thickness across quadrants and eccentricities in a heterogeneous adult population and to evaluate the anatomical adequacy of fixed-depth suprachoroidal injection strategies currently used in clinical practice.
Design: A cross-sectional observational study.
Methods: A total of 110 eyes from 110 participants (18-75 years; +3.00 to -11.00D) were included. Swept-source anterior segment optical coherence tomography was used to measure central corneal thickness, anterior scleral thickness (AST), conjunctival-tenon capsule thickness, anterior choroidal thickness, anterior conjunctival-scleral thickness, and anterior conjunctival-scleral-choroidal thickness. Measurements were obtained in four quadrants at 0 to 5 mm posterior to the scleral spur at 1-mm intervals. Associations between thickness parameters and demographic, refractive, and anatomical factors were analyzed using mixed-effects models. The frequency of measurements below commonly used suprachoroidal injection depths (900 and 1100 µm) was determined.
Results: Anterior ocular wall thickness exhibited marked spatial variability across quadrants (P < .001), decreasing sharply 1 to 2 mm posterior to the scleral spur before stabilizing. At 4 mm posterior to the scleral spur, all eyes exhibited AST values below 900 µm, and anterior conjunctival-scleral-choroidal thickness was below 900 µm in 63.64% of eyes. AST was independently associated with age and central corneal thickness but showed no association with spherical equivalent or axial length.
Conclusions: Anterior ocular wall thickness varies substantially by quadrant and eccentricity. While fixed-depth needles are clinically safe, understanding this anatomical variation may clarify injection mechanics and support anatomically guided approaches to optimize suprachoroidal drug delivery.
Copyright © 2026. Published by Elsevier Inc.